Rare Cancers Bill 2024-2025
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.

HIV and AIDS statistics: UK. By Rachael Harker. SN/SG/2210. This note summarises recent statistics on Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and also includes a POSTBOX on HIV Infection and Treatment. Section 1 describes how the numbers of those diagnosed with and those dying from HIV/AIDS in the UK have changed over time. The characteristics that put people most at risk of HIV are considered in Sections 2 and the manner and place in which individuals with HIV acquire their infection in examined in Section 3. The general prevalence of HIV, and levels of awareness of infection, are examined in Section 4. International statistics on HIV and AIDS are briefly considered in Section 5, while Section 6 looks at public knowledge and attitudes to the disease.
HIV and AIDS statistics: UK (173 KB , PDF)
HIV and AIDS statistics: UK. By Rachael Harker. SN/SG/2210.
This note summarises recent statistics on Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) and also includes a POSTBOX on HIV Infection and Treatment.
Section 1 describes how the numbers of those diagnosed with and those dying from HIV/AIDS in the UK have changed over time.
The characteristics that put people most at risk of HIV are considered in Sections 2 and the manner and place in which individuals with HIV acquire their infection in examined in Section 3. The general prevalence of HIV, and levels of awareness of infection, are examined in Section 4. International statistics on HIV and AIDS are briefly considered in Section 5, while Section 6 looks at public knowledge and attitudes to the disease.
HIV and AIDS statistics: UK (173 KB , PDF)
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
General guidance on dealing with questions of British citizenship and passports.